Capacity building for big genome data


Following the example of the UK, France is (only) the second big country in Europe to embark on a co-ordinated national project to bring genomics into regular care. Proponents of such schemes argue that they are a necessary milestone on the way towards patient-centric big data analytics.

The French Plan for Genomic Medicine 2025 (‘Plan France Médecine Génomique 2025’) was handed over to Prime Minister Manuel Valls on 22 June 2016. The ambitious goal is to make France a leader in genomic medicine within a decade, to support the delivery of personalised, participatory medicine, and to help create an industrial sector for genomic medicine. To this end, the French government has made it clear that it will fully support the implementation of the plan that proposes initial investment of €670m over five years plus commercial contributions worth another €230m.

The main focus of the French genomics plan is to build capacities for genome sequencing and to establish instruments that make genome analytics available to medical institutions, researchers, and also, to a certain extent, patients and their families. The idea is to create a network of twelve sequencing centres, plus two national centres for expert analysis. With this infrastructure, co-ordinated but not run by the organisation France-Genomique, the French are planning to process 235,000 genomes per year including transcriptome and exome sequencing.

View in full – Capacity Building For Big Genome Data